ACACA and metabolic syndrome: In HepG2 cells under in vitro conditions mimicking steatosis, insulin resistance, and MetS, we found increased protein expression of ACC1, which was reduced by LOLA in the conditions of steatosis and insulin resistance (Figure 4C).